BioSpace News Archive

New Nasal Saline Mist, FEND, Shown to Reduce Airborne Particles in Exhaled Air by 99% for up to Six Hours; Designed to Clean Away the Airway Droplets that are Too Small for Conventional Face Masks to Capture

Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, has signed a new distribution agreement with American Medical Depot “AMD,” one of the nation’s largest and diversified government healthcare distributors. As part of the agreement, the two parties are set to provide Daxor’s BVA-100 diagnostic blood test (Blood Volume Analysis) “BVA,” to gov

Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, today announced the launch of MOSES 2.0, the next generation of the versatile, patented MOSES platform that is redefining urology care.

- A special meeting of stockholders (the “Meeting”) is scheduled for 9:00 a.m. PST on Thursday, July 16, 2020. - The sole purpose of the Meeting is to seek approval of a proposal to amend Titan’s certificate of incorporation to increase the number of authorized shares of common stock. - The amendment requires the favorable vote of 47,830,178 shares, a majority of the shares outstanding on the record date of May 22, 2020. - More affirmative votes are needed

Takeda Pharmaceutical Company Limited (“Takeda”) ( TSE:4502/NYSE:TAK ) and the New York Academy of Sciences announced today the Winners of the third annual Innovators in Science Award for their excellence in and commitment to innovative science that has significantly advanced the field of rare disease research. Each Winner receives a pri

ImmunoMolecular Therapeutics, Inc. (“IM Therapeutics”), a leading innovator in the field of precision medicine for autoimmune disease, announced today that Mr. Tom Shea and Dr. Sarah Bird have joined its senior management team. Tom has joined as Chief Financial Officer and Chief Operating Officer (CFO/COO) and Sarah has been promoted to the position of Vice President, Clinical Development. Tom has over 30 years of prof

Eko today announced the appointment of digital health sales veteran Bryan Humbarger to the position of Senior Vice President, Commercial.

Voltron Therapeutics, Inc. announced today it has initiated preclinical animal testing of the first construct of its HaloVax Self-Assembling Vaccine (SAV) against COVID-19. Voltron will take two different vaccines, with differing sets of targets into preclinical testing, in order to identify the best balance of immune responses for prevention of this pandemic pathogen. HaloVax is being developed in conjunction with Hoth Therapeutics, Inc. (NASDAQ

Renalytix AI plc (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, today announced that it has signed an agreement to become a provider in the America’s Choice Provider Network (ACPN).

GoHealth, Inc. (“GoHealth”), a leading health insurance marketplace, today announced that it has commenced an initial public offering of 39,500,000 shares of its Class A common stock